Elsevier,

The Lancet Regional Health - Americas, Volume 37, September 2024

This viewpoint highlights the threat of gambling as an emerging public health issue in the American continent.
A non invasive way to test stress levels an monitor metal health in the work environment.
Special Issue logo featuring Elsevier logo and outline of brain

September 21 is World Alzheimer's Day. To mark the event, Elsevier has curated a free to access, special collection of 50+ pieces of the latest research to advance knowledge and understanding of Alzheimer's and other forms of dementia. #KnowDementia #KnowAlzheimers

We Empower Challenge logo on purple background

On Wednesday 25th September 2024, the five 2024 WE Empower awardees will take part in the WE Empower SDG Challenge Pitch Night.  Hosted by fashion designer, author and philanthropist, Diane Von Fur

This chapter aligns with several SDG goals. Goal 3: Good Health and Well-Being: the chapter discusses the poor health status and health disparities faced by Indigenous populations globally (higher rates of infant mortality, maternal mortality, malnutrition etc.) and advocates for targeted policy responses and improved access to healthcare services. Goal 10: the chapter discusses the social, economic, and political marginalization of Indigenous peoples worldwide, describing how Indigenous communities are often denied self-determination, face ongoing loss of land and resources, and experience systemic discrimination. Goal 15: Life on Land: the chapter discusses the close relationship between the health of Indigenous peoples and the health of their traditional lands and ecosystems. It highlights the importance of biodiversity conservation and the need to recognize the rights of Indigenous communities to their ancestral territories and natural resources.

Steroidal alkaloids from bioactive sources as a potential therapeutic approach to managing Alzheimer’s. It is a review, but I think it shines a really unique light in underexplored, and oft inexpensive, approaches.
The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Nurse practitioners and other health care providers can play a crucial role in implementing chronic disease management strategies and educating patients who are at risk for AD among African Americans and Hispanics.
Despite significant investment, effective treatments for Alzheimer's disease (AD) have been elusive, necessitating improved quality and reproducibility of foundational laboratory evidence; to address this, AD-SOLES, an integrated workflow of automated tools and a publicly accessible interactive dashboard, has been developed to collect, curate, and visualize in vivo experimental evidence, enhancing evidence synthesis, tracking reporting quality, and aiding researchers in locating relevant data.
The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s

Pages